FONDAZIONE TELETHON ANNOUNCES FDA APPROVAL OF WASKYRA™ (ETUVETIDIGENE AUTOTEMCEL), A GENE THERAPY FOR THE TREATMENT OF WISKOTT-ALDRICH SYNDROME

Reuters · 2d ago

Please log in to view news